 Halden Scott
Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sepsis | 45 | 2026 | 641 | 10.290 |
Why?
| | Shock, Septic | 21 | 2026 | 216 | 4.550 |
Why?
| | Emergency Service, Hospital | 21 | 2025 | 2313 | 2.550 |
Why?
| | Hospital Mortality | 16 | 2026 | 1031 | 2.050 |
Why?
| | Multiple Organ Failure | 8 | 2024 | 124 | 1.640 |
Why?
| | Hospitals, Pediatric | 9 | 2023 | 557 | 1.430 |
Why?
| | Lactic Acid | 4 | 2020 | 302 | 1.360 |
Why?
| | Systemic Inflammatory Response Syndrome | 4 | 2024 | 96 | 1.230 |
Why?
| | Child | 56 | 2026 | 22657 | 1.180 |
Why?
| | Organ Dysfunction Scores | 9 | 2024 | 53 | 1.170 |
Why?
| | Intensive Care Units, Pediatric | 7 | 2025 | 285 | 1.090 |
Why?
| | Critical Care | 9 | 2021 | 697 | 0.790 |
Why?
| | Quality Improvement | 6 | 2026 | 1291 | 0.750 |
Why?
| | Child, Preschool | 26 | 2026 | 11799 | 0.690 |
Why?
| | Infant | 25 | 2026 | 10039 | 0.690 |
Why?
| | Decision Support Systems, Clinical | 1 | 2025 | 265 | 0.680 |
Why?
| | Guideline Adherence | 4 | 2023 | 589 | 0.670 |
Why?
| | Electronic Health Records | 5 | 2026 | 1177 | 0.640 |
Why?
| | Hyperlactatemia | 1 | 2019 | 2 | 0.610 |
Why?
| | Thiamine Deficiency | 1 | 2019 | 9 | 0.600 |
Why?
| | Anti-Bacterial Agents | 11 | 2025 | 1915 | 0.600 |
Why?
| | Quality of Health Care | 2 | 2023 | 693 | 0.590 |
Why?
| | Machine Learning | 5 | 2025 | 587 | 0.560 |
Why?
| | Hospitals | 2 | 2021 | 732 | 0.540 |
Why?
| | Humans | 63 | 2026 | 144957 | 0.530 |
Why?
| | Community Health Centers | 1 | 2018 | 59 | 0.530 |
Why?
| | Pediatrics | 7 | 2024 | 1115 | 0.530 |
Why?
| | Patient Admission | 1 | 2019 | 218 | 0.530 |
Why?
| | Motivation | 1 | 2022 | 610 | 0.520 |
Why?
| | Adolescent | 26 | 2026 | 22453 | 0.510 |
Why?
| | Tertiary Care Centers | 1 | 2018 | 189 | 0.500 |
Why?
| | Diagnostic Errors | 1 | 2018 | 175 | 0.490 |
Why?
| | Physical Examination | 2 | 2015 | 240 | 0.490 |
Why?
| | Retrospective Studies | 21 | 2026 | 17101 | 0.490 |
Why?
| | Sensitivity and Specificity | 7 | 2026 | 1990 | 0.470 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 266 | 0.450 |
Why?
| | Severity of Illness Index | 3 | 2020 | 2925 | 0.450 |
Why?
| | Risk Assessment | 3 | 2020 | 3676 | 0.440 |
Why?
| | Intubation, Intratracheal | 1 | 2018 | 320 | 0.440 |
Why?
| | Meningitis | 1 | 2015 | 80 | 0.430 |
Why?
| | Fluid Therapy | 4 | 2020 | 147 | 0.420 |
Why?
| | Hospitalization | 6 | 2026 | 2434 | 0.400 |
Why?
| | Lactates | 1 | 2012 | 83 | 0.370 |
Why?
| | Time-to-Treatment | 2 | 2025 | 245 | 0.370 |
Why?
| | Algorithms | 1 | 2019 | 1839 | 0.350 |
Why?
| | Length of Stay | 5 | 2021 | 1337 | 0.350 |
Why?
| | Practice Guidelines as Topic | 5 | 2026 | 1563 | 0.340 |
Why?
| | Albumins | 1 | 2011 | 118 | 0.340 |
Why?
| | Critical Illness | 4 | 2021 | 892 | 0.330 |
Why?
| | Sodium Chloride | 1 | 2011 | 142 | 0.330 |
Why?
| | Shock | 1 | 2011 | 108 | 0.320 |
Why?
| | Male | 26 | 2026 | 72406 | 0.320 |
Why?
| | Intensive Care Units | 2 | 2021 | 916 | 0.310 |
Why?
| | Female | 26 | 2026 | 78376 | 0.290 |
Why?
| | Guidelines as Topic | 2 | 2020 | 268 | 0.270 |
Why?
| | Cohort Studies | 6 | 2020 | 5965 | 0.250 |
Why?
| | Infant, Newborn | 10 | 2026 | 6434 | 0.240 |
Why?
| | Prognosis | 4 | 2022 | 4293 | 0.240 |
Why?
| | Early Diagnosis | 3 | 2025 | 249 | 0.240 |
Why?
| | Vasoconstrictor Agents | 4 | 2020 | 144 | 0.230 |
Why?
| | Epidemiological Monitoring | 1 | 2026 | 69 | 0.230 |
Why?
| | International Classification of Diseases | 3 | 2015 | 147 | 0.230 |
Why?
| | Blood Culture | 1 | 2025 | 25 | 0.220 |
Why?
| | Febrile Neutropenia | 1 | 2023 | 6 | 0.210 |
Why?
| | Emergency Treatment | 2 | 2022 | 124 | 0.200 |
Why?
| | Prospective Studies | 4 | 2025 | 7997 | 0.200 |
Why?
| | Registries | 4 | 2025 | 2385 | 0.190 |
Why?
| | Bacteremia | 1 | 2025 | 221 | 0.190 |
Why?
| | Population Surveillance | 1 | 2026 | 485 | 0.190 |
Why?
| | Respiration, Artificial | 4 | 2022 | 708 | 0.180 |
Why?
| | Computer-Assisted Instruction | 1 | 2021 | 71 | 0.170 |
Why?
| | Resuscitation | 3 | 2020 | 302 | 0.160 |
Why?
| | Education, Continuing | 1 | 2020 | 41 | 0.160 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2020 | 32 | 0.160 |
Why?
| | Bacterial Infections | 1 | 2022 | 246 | 0.160 |
Why?
| | Patient Outcome Assessment | 1 | 2021 | 134 | 0.160 |
Why?
| | Positive-Pressure Respiration | 1 | 2020 | 112 | 0.150 |
Why?
| | Thiamine | 1 | 2019 | 18 | 0.150 |
Why?
| | Immunocompromised Host | 1 | 2020 | 201 | 0.140 |
Why?
| | Incidence | 3 | 2026 | 2883 | 0.140 |
Why?
| | New York | 1 | 2018 | 127 | 0.140 |
Why?
| | Data Collection | 1 | 2021 | 635 | 0.140 |
Why?
| | Drug Utilization Review | 1 | 2017 | 61 | 0.130 |
Why?
| | Veins | 1 | 2017 | 68 | 0.130 |
Why?
| | Patient Care Bundles | 1 | 2017 | 28 | 0.130 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 90 | 0.120 |
Why?
| | Evidence-Based Medicine | 3 | 2026 | 732 | 0.120 |
Why?
| | Arteries | 1 | 2017 | 259 | 0.110 |
Why?
| | Logistic Models | 2 | 2025 | 2119 | 0.110 |
Why?
| | Heart Rate | 2 | 2021 | 855 | 0.110 |
Why?
| | Hypotension | 1 | 2015 | 126 | 0.110 |
Why?
| | Prevalence | 4 | 2015 | 2836 | 0.110 |
Why?
| | Abscess | 2 | 2017 | 75 | 0.110 |
Why?
| | Patient Discharge | 1 | 2021 | 983 | 0.100 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1268 | 0.100 |
Why?
| | Body Temperature | 1 | 2015 | 229 | 0.100 |
Why?
| | Acute Kidney Injury | 1 | 2021 | 866 | 0.100 |
Why?
| | Hemodynamics | 4 | 2020 | 1121 | 0.100 |
Why?
| | Mass Screening | 1 | 2021 | 1348 | 0.090 |
Why?
| | Time Factors | 3 | 2024 | 7183 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3415 | 0.090 |
Why?
| | Likelihood Functions | 1 | 2012 | 143 | 0.090 |
Why?
| | United States | 8 | 2026 | 15988 | 0.090 |
Why?
| | Confidence Intervals | 1 | 2012 | 333 | 0.090 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2015 | 342 | 0.090 |
Why?
| | Heart Arrest | 1 | 2015 | 407 | 0.090 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 2 | 2011 | 249 | 0.080 |
Why?
| | Emergency Medical Services | 2 | 2015 | 696 | 0.080 |
Why?
| | Proteus mirabilis | 1 | 2010 | 3 | 0.080 |
Why?
| | Proteus Infections | 1 | 2010 | 5 | 0.080 |
Why?
| | Staphylococcal Skin Infections | 1 | 2011 | 43 | 0.080 |
Why?
| | Cause of Death | 1 | 2012 | 472 | 0.080 |
Why?
| | Skin Diseases, Infectious | 1 | 2010 | 13 | 0.080 |
Why?
| | Skin Diseases, Bacterial | 1 | 2010 | 22 | 0.080 |
Why?
| | Global Health | 2 | 2024 | 401 | 0.080 |
Why?
| | Soft Tissue Infections | 1 | 2010 | 39 | 0.080 |
Why?
| | Colorado | 1 | 2019 | 4564 | 0.070 |
Why?
| | ROC Curve | 2 | 2022 | 615 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2884 | 0.070 |
Why?
| | Biomarkers | 2 | 2017 | 4275 | 0.070 |
Why?
| | Consensus | 2 | 2020 | 489 | 0.070 |
Why?
| | Sex Factors | 1 | 2012 | 2114 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2025 | 2118 | 0.060 |
Why?
| | Datasets as Topic | 1 | 2026 | 122 | 0.060 |
Why?
| | Risk Factors | 2 | 2018 | 10792 | 0.060 |
Why?
| | Age Factors | 1 | 2012 | 3335 | 0.060 |
Why?
| | Cardiovascular Agents | 2 | 2017 | 164 | 0.050 |
Why?
| | Monitoring, Physiologic | 2 | 2017 | 289 | 0.050 |
Why?
| | Wearable Electronic Devices | 1 | 2024 | 63 | 0.050 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2017 | 383 | 0.040 |
Why?
| | Consciousness | 1 | 2022 | 34 | 0.040 |
Why?
| | Patient Acuity | 1 | 2022 | 47 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2026 | 1095 | 0.040 |
Why?
| | Mobile Applications | 1 | 2024 | 196 | 0.040 |
Why?
| | Electronics | 1 | 2021 | 71 | 0.040 |
Why?
| | Clinical Laboratory Techniques | 1 | 2022 | 96 | 0.040 |
Why?
| | Medical Oncology | 1 | 2023 | 332 | 0.040 |
Why?
| | Practice Patterns, Physicians' | 1 | 2010 | 1358 | 0.040 |
Why?
| | Artificial Intelligence | 1 | 2024 | 367 | 0.040 |
Why?
| | Healthcare Disparities | 1 | 2026 | 728 | 0.040 |
Why?
| | Complement Activation | 1 | 2021 | 411 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2026 | 5872 | 0.030 |
Why?
| | Pyomyositis | 1 | 2017 | 15 | 0.030 |
Why?
| | Learning | 1 | 2021 | 452 | 0.030 |
Why?
| | Anti-Infective Agents | 1 | 2020 | 242 | 0.030 |
Why?
| | Central Venous Catheters | 1 | 2017 | 53 | 0.030 |
Why?
| | Medical Records | 1 | 2017 | 189 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2020 | 1325 | 0.030 |
Why?
| | Drug Utilization | 1 | 2017 | 167 | 0.030 |
Why?
| | Arthritis, Infectious | 1 | 2017 | 72 | 0.030 |
Why?
| | Atropine | 1 | 2015 | 37 | 0.030 |
Why?
| | Fever | 1 | 2017 | 312 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2015 | 39 | 0.030 |
Why?
| | Ventricular Fibrillation | 1 | 2015 | 64 | 0.030 |
Why?
| | Osteomyelitis | 1 | 2017 | 143 | 0.030 |
Why?
| | Emergency Responders | 1 | 2015 | 37 | 0.030 |
Why?
| | Early Medical Intervention | 1 | 2015 | 61 | 0.030 |
Why?
| | Electric Countershock | 1 | 2015 | 127 | 0.030 |
Why?
| | Curriculum | 1 | 2021 | 1060 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 1031 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 2015 | 242 | 0.030 |
Why?
| | Research Design | 1 | 2020 | 1137 | 0.020 |
Why?
| | Anesthesia | 1 | 2017 | 258 | 0.020 |
Why?
| | Patient Readmission | 1 | 2017 | 759 | 0.020 |
Why?
| | Clindamycin | 1 | 2010 | 14 | 0.020 |
Why?
| | Axilla | 1 | 2010 | 51 | 0.020 |
Why?
| | Cellulitis | 1 | 2010 | 53 | 0.020 |
Why?
| | Treatment Failure | 1 | 2011 | 365 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2010 | 539 | 0.020 |
Why?
| | Community-Acquired Infections | 1 | 2010 | 174 | 0.020 |
Why?
| | Adult | 2 | 2022 | 40506 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2017 | 11695 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 14126 | 0.010 |
Why?
|
|
Scott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|